Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
ADI Analog Devices Inc
BAC Bank of America Corp
CLOV Clover Health Investments Corp
HRL Hormel Foods Corp
DD Dupont De Nemours Inc
PSRU Valiant Eagle Inc
CRM Salesforce.Com Inc
VLYPP Valley National Bancorp
FEMKX Fidelity® Emerging Markets Fund
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

Postmarket

Last Trade
Delayed
$226.25
0.56 (0.25%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$225.69
Day's Change
-1.35 (-0.59%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
227.89
Day's Low
225.28
Volume
(Average)
Volume:
2,407,583

10-day average volume:
2,435,602
2,407,583

Upcoming Events

AMGN's fiscal year ends in December
There are no upcoming events for AMGN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
Earnings
estimate range
Previous year's
actual
February 2, 2021Q4 2020 Earnings Release$3.81$3.09 to $4.07$3.64
October 28, 2020Q3 2020 Earnings Release$4.37$3.47 to $4.16$3.66
July 28, 2020Q2 2020 Earnings Release$4.25$3.10 to $4.21$3.97
April 30, 2020Q1 2020 Earnings Release$4.17$3.19 to $4.09$3.56

Past Dividends

Ex-dividend dateAmountRecord datePay date
February 11, 2021$1.76February 15, 2021March 8, 2021
November 13, 2020$1.60November 16, 2020December 8, 2020
August 14, 2020$1.60August 17, 2020September 8, 2020
May 15, 2020$1.60May 18, 2020June 8, 2020

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.